Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bode

Showing results (581-590 of 756) with videos related to

Pageof 76
Sort By:
Atherosclerosis. Supplements|November 4, 2017
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathyRoman N Rodionov, Annett Heinrich, Silke Brilloff, et al.
Molecular Carcinogenesis|December 21, 2007
Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformationZhiwei He, Faqing Tang, Svetlana Ermakova, et al.
Carcinogenesis|October 18, 2017
The CUG-translated WT1, not AUG-WT1, is an oncogeneKun Yeong Lee, Young Jin Jeon, Hong Gyum Kim, et al.
Carcinogenesis|December 24, 2010
P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformationTingting Li, Jishuai Zhang, Feng Zhu, et al.
Oncogene|January 16, 2013
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stabilityW Wen, C Peng, M O Kim, et al.
Carcinogenesis|November 28, 2012
(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cellsSufang Liu, Hongde Li, Lin Chen, et al.
Nature Structural & Molecular Biology|July 12, 2005
The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activityBu Young Choi, Hong Seok Choi, Kwangseok Ko, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 27, 2010
Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremiaN J Verkaik, H A Boelens, C P de Vogel, et al.
Oncogene|August 24, 2011
Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradationJ Zhang, F Zhu, X Li, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 28, 2011
Chronic renal failure alters endothelial function in cerebral circulation in miceJean-Marc Bugnicourt, Charlène Da Silveira, Abderrahmane Bengrine, et al.
Pageof 76

Showing results (581-590 of 756) with videos related to

Sort By:
Pageof 76
Atherosclerosis. Supplements|November 4, 2017
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathyRoman N Rodionov, Annett Heinrich, Silke Brilloff, et al.
Molecular Carcinogenesis|December 21, 2007
Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformationZhiwei He, Faqing Tang, Svetlana Ermakova, et al.
Carcinogenesis|October 18, 2017
The CUG-translated WT1, not AUG-WT1, is an oncogeneKun Yeong Lee, Young Jin Jeon, Hong Gyum Kim, et al.
Carcinogenesis|December 24, 2010
P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformationTingting Li, Jishuai Zhang, Feng Zhu, et al.
Oncogene|January 16, 2013
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stabilityW Wen, C Peng, M O Kim, et al.
Carcinogenesis|November 28, 2012
(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cellsSufang Liu, Hongde Li, Lin Chen, et al.
Nature Structural & Molecular Biology|July 12, 2005
The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activityBu Young Choi, Hong Seok Choi, Kwangseok Ko, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 27, 2010
Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremiaN J Verkaik, H A Boelens, C P de Vogel, et al.
Oncogene|August 24, 2011
Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradationJ Zhang, F Zhu, X Li, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 28, 2011
Chronic renal failure alters endothelial function in cerebral circulation in miceJean-Marc Bugnicourt, Charlène Da Silveira, Abderrahmane Bengrine, et al.
Pageof 76